Page last updated: 2024-10-26

etidronate and Mouth Ulcer

etidronate has been researched along with Mouth Ulcer in 2 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Research Excerpts

ExcerptRelevanceReference
" However, there seems to be a limited awareness that oral bisphosphonates can also induce adverse effects in the soft tissues of the oral cavity, as indicated by the paucity of reported cases in the literature."1.38Pharmacovigilance of oral bisphosphonates: adverse effects manifesting in the soft tissue of the oral cavity. ( Kharazmi, M; Persson, U; Warfvinge, G, 2012)
"Most reports of osteonecrosis are attributed to the use of bisphosphonates administered intravenously for the treatment of bone disorders such as multiple myeloma."1.35Osteonecrosis associated with short-term oral administration of bisphosphonate. ( Harada, A; Sumi, Y; Takagi, Y, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takagi, Y1
Sumi, Y1
Harada, A1
Kharazmi, M1
Persson, U1
Warfvinge, G1

Other Studies

2 other studies available for etidronate and Mouth Ulcer

ArticleYear
Osteonecrosis associated with short-term oral administration of bisphosphonate.
    The Journal of prosthetic dentistry, 2009, Volume: 101, Issue:5

    Topics: Administration, Oral; Aged; Bone Density Conservation Agents; Denture, Partial, Removable; Etidronic

2009
Pharmacovigilance of oral bisphosphonates: adverse effects manifesting in the soft tissue of the oral cavity.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2012, Volume: 70, Issue:12

    Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Alendronate;

2012